Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics for COVID-19. Here, we e...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:bioRxiv
Glavni autori: Bates, Timothy A., Weinstein, Jules B., Farley, Scotland E., Leier, Hans C., Messer, William B., Tafesse, Fikadu G.
Format: Artigo
Jezik:Inglês
Izdano: Cold Spring Harbor Laboratory 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402058/
https://ncbi.nlm.nih.gov/pubmed/32766589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.30.229377
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items